Results 101 to 110 of about 5,707 (185)

How to Define Success in Prolactinoma Treatment-A Systematic Review and Theoretical Framework.

J Clin Endocrinol Metab
van Trigt VR, Huynh KA, Bakker LEH, Pelsma ICM, Zandbergen IM, Zamanipoor Najafabadi AH, Verstegen MJT, van Furth WR, Biermasz NR.   +8 more
europepmc   +1 more source

Deguelin inhibits growth and prolactin synthesis in prolactinomas by targeting the PI3K/AKT/CREB3L1 pathway and ornithine decarboxylase. [PDF]

Acta Pharmacol Sin
Gong L, Liu CX, Cheng JH, Guo J, Li B, Wang HY, Liu M, Wang JL, Li XJ, Fang QY, Yi ZY, Li CZ, Zhang YZ, Xie WY.   +13 more
europepmc   +1 more source

Management outcomes of prolactinoma: a retrospective study from Southern Iraq. [PDF]

J Med Life
Alobaidy HF, Alidrisi HA, Reman KA, Alzujajy QB, Hussein IH, Mansour AA.   +5 more
europepmc   +1 more source

Temozolomide in aggressive and metastatic pituitary tumors: a Brazilian multicenter real-world cohort study. [PDF]

Pituitary
de Magalhães IPA, de Macedo CRPB, Naves LA, Czepielewski MA, Rosa IN, de Santana LB, de Almeida TS, Padula M, Elias PCL, de Castro M, Kasuki L, Gadelha MR, Rech CGSL, Garmes HM, Boguszewski CL, Jallad RS, Nakaguma M, Fragoso MCBV, Machado MC, Glezer A, da Cunha Neto MBC, Feher O, Batista RL.   +22 more
europepmc   +1 more source

Management for prolactinomas of postmenopausal female patients: a retrospective single-center study. [PDF]

BMC Endocr Disord
Chen X, Lu Y, Liu J, Ke X, Miao H, Duan L, Gong F, Yang H, Pan H, Wang L, Zhu H.   +10 more
europepmc   +1 more source

Therapeutic challenges of giant invasive cystic macroprolactinoma. [PDF]

Endocrinol Diabetes Metab Case Rep
Mekni S, Khiari H, Bouali S, Laamouri R, Essayeh S, Rojbi I, Ben Nacef I.   +6 more
europepmc   +1 more source

Subtle Cognitive Impairments and Psychological Complaints in Patients With Prolactinoma Despite Biochemical Control.

J Clin Endocrinol Metab
van Trigt VR, Andela CD, Bakker LEH, Brama SCM, Schmidt LE, Sneekes FM, Zeelenberg MW, Huisman SD, Bauduin SEEC, Dekkers OM, Verstegen MJT, van Furth WR, Pelsma ICM, Biermasz NR.   +13 more
europepmc   +1 more source

Multiple endocrine neoplasia with an atypical clinical course and a MEN1 gene variant of uncertain pathogenicity: A case report. [PDF]

Medicine (Baltimore)
Sato S, Arahata M, Kumano Y, Kawai K.
europepmc   +1 more source

Somatostatin 5 receptor expression in prolactinomas: Is there a role for Pasireotide in the management of prolactinomas? [PDF]

Pituitary
Agrawal N, Mehta S, Feelders RA, Skwiersky S, Campana C, Dogan F, van Koetsveld PM, Neggers SJCMM, Wright K, Kim H, Zagzag D, Hofland LJ.   +11 more
europepmc   +1 more source

Cabergoline-Resistant Recurrent Macroprolactinoma During Pregnancy: A Case Report and Review of the Literature. [PDF]

Cureus
Alajpur S, Gill VJS, McCleery A, Mullarkey-Desapio CJ.   +3 more
europepmc   +1 more source